SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-20-000081
Filing Date
2020-11-20
Accepted
2020-11-20 16:48:46
Documents
2
Period of Report
2020-11-16
Items
Item 1.03: Bankruptcy or Receivership
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED NOVEMBER 16, 2020 RE: REORGANIZATION form8kdtd111620.htm 8-K 49700
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION ex3_1.htm EX-3.1 5818
  Complete submission text file 0001021771-20-000081.txt   57156
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 201333144
SIC: 8090 Services-Misc Health & Allied Services, NEC